• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含RNA免疫复合物在免疫细胞和肌肉中激活TLR7/8:在炎症和肌炎发病机制中的作用

TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis.

作者信息

Wu Yin, Deshpande Aditee, Geraci Nicholas, Budde Petra, Sellers Vera, Velisetty Phanindra, Sun Chia-Chi, Strand Fatima, Bhavsar Carmina, Niewold Timothy B, Jensen Mark A, Kalatskaya Irina, Sarin Kavita Y, Fiorentino David, Bender Andrew T

机构信息

EMD Serono, Billerica, Massachusetts.

Oncimmune Germany GmbH, Dortmund, Germany.

出版信息

Arthritis Rheumatol. 2025 Feb;77(2):190-201. doi: 10.1002/art.42989. Epub 2024 Nov 4.

DOI:10.1002/art.42989
PMID:39279150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11782111/
Abstract

OBJECTIVE

Activation of endosomal toll-like receptors (TLRs) is one possible driver of inflammation in idiopathic inflammatory myopathies (IIM). We investigated the potential contribution of TLR7 and TLR8 to IIM pathogenesis.

METHODS

Activation of TLR7/8 in healthy donor peripheral blood mononuclear cells (PBMCs) by immune complexes from patients with IIMs and lupus was tested. Autoantibody profiling of patient IgG samples was performed using a 1581 antigen array. TLR7 and/or TLR8 activation by RNA molecules associated with autoantibodies was assessed. Gene expression in human myoblasts and satellite cells following treatment with supernatants from TLR7/8-activated PBMCs was evaluated by NanoString. C57BL/6 mice were dosed intramuscularly with the TLR7/8 agonist R848 and single-cell RNA-sequencing was performed on the muscle to ascertain the cell types responding to TLR7/8 activation and the downstream effects.

RESULTS

Overall, 69 patients with IIMs were included with representation of dermatomyositis, polymyositis, and inclusion body myositis subsets. Immune complexes from patients with IIMs, as well as autoantibody-associated RNAs histidyl-transfer RNA, Y1, Y4, and U1, activated PBMCs to produce interferon-α and IL-6 via TLR7/8. Several canonical (Ro60, Ro52, and HIST1H4A) and novel (IL-36RN) autoreactivities correlated highly with TLR7/8 activation. Supernatants from TLR7/8-activated PBMCs had a negative impact on human myoblasts and satellite cells. Endothelial cells were activated by R848 in mouse muscle in vivo in addition to immune cells such as monocytes and macrophages.

CONCLUSION

Our results suggest that patients with IIMs have autoantibodies in their blood causing TLR7/8 activation, which leads to inflammation in muscles with potential deleterious effects.

摘要

目的

内体 toll 样受体(TLR)的激活是特发性炎性肌病(IIM)炎症的一个可能驱动因素。我们研究了 TLR7 和 TLR8 对 IIM 发病机制的潜在作用。

方法

测试了 IIM 患者和狼疮患者的免疫复合物对健康供体外周血单个核细胞(PBMC)中 TLR7/8 的激活作用。使用 1581 抗原阵列对患者 IgG 样本进行自身抗体谱分析。评估了与自身抗体相关的 RNA 分子对 TLR7 和/或 TLR8 的激活作用。通过 NanoString 评估用 TLR7/8 激活的 PBMC 上清液处理后人成肌细胞和卫星细胞中的基因表达。对 C57BL/6 小鼠进行肌肉内注射 TLR7/8 激动剂 R848,并对肌肉进行单细胞 RNA 测序,以确定对 TLR7/8 激活作出反应的细胞类型及其下游效应。

结果

总体而言,纳入了 69 例 IIM 患者,包括皮肌炎、多发性肌炎和包涵体肌炎亚组。IIM 患者的免疫复合物以及自身抗体相关的 RNA(组氨酰 - 转运 RNA、Y1、Y4 和 U1)通过 TLR7/8 激活 PBMC 产生干扰素 -α和白细胞介素 -6。几种典型的(Ro60、Ro52 和 HIST1H4A)和新发现的(IL - 36RN)自身反应性与 TLR7/8 激活高度相关。TLR7/8 激活的 PBMC 上清液对人成肌细胞和卫星细胞有负面影响。除了单核细胞和巨噬细胞等免疫细胞外,R848 在体内还激活了小鼠肌肉中的内皮细胞。

结论

我们的结果表明,IIM 患者血液中的自身抗体导致 TLR7/8 激活,进而导致肌肉炎症并可能产生有害影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/b2686476cef1/ART-77-190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/c3a988b24236/ART-77-190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/ec77d74cf98d/ART-77-190-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/17fa13b3ee2a/ART-77-190-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/b9dc81ca6739/ART-77-190-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/4e23dbc90f7a/ART-77-190-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/b2686476cef1/ART-77-190-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/c3a988b24236/ART-77-190-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/ec77d74cf98d/ART-77-190-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/17fa13b3ee2a/ART-77-190-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/b9dc81ca6739/ART-77-190-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/4e23dbc90f7a/ART-77-190-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e4/11782111/b2686476cef1/ART-77-190-g003.jpg

相似文献

1
TLR7/8 Activation in Immune Cells and Muscle by RNA-Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis.含RNA免疫复合物在免疫细胞和肌肉中激活TLR7/8:在炎症和肌炎发病机制中的作用
Arthritis Rheumatol. 2025 Feb;77(2):190-201. doi: 10.1002/art.42989. Epub 2024 Nov 4.
2
Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.持续的 Toll 样受体 7 刺激诱导行为和分子固有免疫耐受。
Brain Behav Immun. 2019 Nov;82:338-353. doi: 10.1016/j.bbi.2019.09.004. Epub 2019 Sep 6.
3
Immune complexes-mediated activation of neutrophils in systemic lupus erythematosus is dependent on RNA recognition by toll-like receptor 8.系统性红斑狼疮中免疫复合物介导的中性粒细胞活化依赖于Toll样受体8对RNA的识别。
Front Immunol. 2024 Dec 24;15:1515469. doi: 10.3389/fimmu.2024.1515469. eCollection 2024.
4
Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.Toll样受体8缺失通过Toll样受体7依赖性机制加速狼疮小鼠模型中的自身免疫反应。
Immunology. 2015 May;145(1):60-70. doi: 10.1111/imm.12426.
5
The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.免疫蛋白酶体是调节特发性炎性肌病肌因子和 MHC Ⅰ类表达的关键。
J Autoimmun. 2016 Dec;75:118-129. doi: 10.1016/j.jaut.2016.08.004. Epub 2016 Aug 10.
6
TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation.Toll样受体7(TLR7)和Toll样受体8(TLR8)在特定细胞类型中差异激活干扰素调节因子(IRF)和核因子κB(NF-κB)信号通路以促进炎症反应。
Immunohorizons. 2020 Feb 21;4(2):93-107. doi: 10.4049/immunohorizons.2000002.
7
Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models.凋亡性肌原前体细胞和 Toll 样受体刺激在实验性自身免疫性肌炎小鼠模型中的必需作用。
Arthritis Rheumatol. 2015 Mar;67(3):809-22. doi: 10.1002/art.38985.
8
Inhibition of miRNA associated with a disease-specific signature and secreted via extracellular vesicles of systemic lupus erythematosus patients suppresses target organ inflammation in a humanized mouse model.抑制与疾病特异性特征相关并通过系统性红斑狼疮患者细胞外囊泡分泌的 miRNA,可抑制人源化小鼠模型中的靶器官炎症。
Front Immunol. 2024 Jun 13;14:1090177. doi: 10.3389/fimmu.2023.1090177. eCollection 2023.
9
Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies.I 型干扰素和 Toll 样受体表达特征性炎性肌病。
Neurology. 2011 Jun 14;76(24):2079-88. doi: 10.1212/WNL.0b013e31821f440a.
10
Exacerbation of Murine Experimental Autoimmune Myositis by Toll-Like Receptor 7/8.TLR7/8 增强实验性自身免疫性肌炎
Arthritis Rheumatol. 2018 Aug;70(8):1276-1287. doi: 10.1002/art.40503. Epub 2018 Jun 27.

引用本文的文献

1
Synovial joints: The barometer of systemic inflammation.滑膜关节:全身炎症的晴雨表。
Acta Pharm Sin B. 2025 Apr;15(4):2287-2289. doi: 10.1016/j.apsb.2024.12.025. Epub 2024 Dec 26.
2
The role of monocytes and macrophages in idiopathic inflammatory myopathies: insights into pathogenesis and potential targets.单核细胞和巨噬细胞在特发性炎性肌病中的作用:对发病机制和潜在靶点的见解
Front Immunol. 2025 Mar 20;16:1567833. doi: 10.3389/fimmu.2025.1567833. eCollection 2025.
3
Gold nanoparticles modulate macrophage polarization to promote skeletal muscle regeneration.

本文引用的文献

1
Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases.在自身免疫性疾病中双重 Toll 样受体 7/8 抑制剂具有潜在的糖皮质激素节约作用的临床前证据。
J Pharmacol Exp Ther. 2024 Feb 15;388(3):751-764. doi: 10.1124/jpet.123.001744.
2
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy.用于狼疮治疗的 Toll 样受体 7/8 拮抗剂 MHV370 的临床前特征。
Cell Rep Med. 2023 May 16;4(5):101036. doi: 10.1016/j.xcrm.2023.101036.
3
The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis.
金纳米颗粒调节巨噬细胞极化以促进骨骼肌再生。
Mater Today Bio. 2025 Mar 11;32:101653. doi: 10.1016/j.mtbio.2025.101653. eCollection 2025 Jun.
Ⅰ型干扰素特征反映皮肌炎的多种表型和活性指标。
Arthritis Rheumatol. 2023 Oct;75(10):1842-1849. doi: 10.1002/art.42526. Epub 2023 Jul 25.
4
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review.特发性炎性肌病中的干扰素:不同的特征和新的治疗前景。文献综述。
Autoimmun Rev. 2023 Jun;22(6):103334. doi: 10.1016/j.autrev.2023.103334. Epub 2023 Apr 15.
5
Towards a Cure for HARS Disease.为治疗 HARS 疾病而努力。
Genes (Basel). 2023 Jan 18;14(2):254. doi: 10.3390/genes14020254.
6
Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren's syndrome: A critical review.并非所有的自身抗体都具有临床意义。干燥综合征中的经典和新型自身抗体:批判性综述。
Front Immunol. 2022 Oct 17;13:1003054. doi: 10.3389/fimmu.2022.1003054. eCollection 2022.
7
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll-like Receptors 7 and 8, in Healthy Volunteers.Toll样受体7和8双重拮抗剂E6742在健康志愿者中的首次人体安全性、耐受性、药代动力学和药效学研究。
Clin Pharmacol Drug Dev. 2023 Apr;12(4):363-375. doi: 10.1002/cpdd.1176. Epub 2022 Oct 11.
8
Autoantibodies: Pathogenic or epiphenomenon.自身抗体:致病还是伴随现象。
Best Pract Res Clin Rheumatol. 2022 Jun;36(2):101767. doi: 10.1016/j.berh.2022.101767. Epub 2022 Jul 7.
9
TLR7 gain-of-function genetic variation causes human lupus.TLR7 获得性功能遗传变异导致人类狼疮。
Nature. 2022 May;605(7909):349-356. doi: 10.1038/s41586-022-04642-z. Epub 2022 Apr 27.
10
TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins.由于一种新的 TLR8 突变导致 TLR8/TLR7 调节异常,在同卵双胞胎中引起严重的自身免疫性溶血性贫血和自身炎症。
Am J Hematol. 2022 Mar 1;97(3):338-351. doi: 10.1002/ajh.26452. Epub 2022 Jan 28.